Oxygen-driven nebulization of Clostridium butyricum prevents drug-resistant bacterial pneumonia.
- 2026-01-24
- RCT · n = 310
- Applied microbiology and biotechnology 110(1)
- Mei-Hua Zhan
- Shuai-Hua Zhan
- Hui-Qiang Han
- Li-Na Kang
- Xin-Gang Yang
- A-Xia Chai
- PubMed: 41580563
- DOI: 10.1007/s00253-026-13716-1
- High evidence
- Large Human Trial
The incidence of pneumonia was 46.45% (72/155) in the control group, compared to only 1.97% (3/152) in the experimental group (relative risk = 23.54, 95%CI: 7.58-73.08).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes